EMA extends real-time release testing role in new guidelines
The EMA has released guidelines extending use of real-time release testing (RTRT) beyond terminally sterilised products.
Archives for April 15, 2012
Improve patient compliance by designing trials around real life, says expert
Designing trials around patients’ habits is the key to success in patient compliance, according to online recruitment specialist Rebar Interactive.
RNA drug firm Arrowhead buys Alvos for delivery tech
RNA therapeutics developer Arrowhead Research has bought Alvos Therapeutics in the hope that peptide targeting technology will help it overcome delivery challenges.
Almac lauds benefits of lean six sigma for IXRS biz
Almac says the adoption of ‘lean six sigma’ was the right move for its clinical technologies business, even taking higher initial training costs into account.
Merck tells FDA a clearer crude heparin definition is needed
Merck & Co has asked the FDA for a “clear and unambiguous” definition of crude heparin to improve draft guidance.
Cetero sale time extended after creditors call it “objectionable”
The Delaware Bankruptcy Court has extended the Cetero sale period by 11 days after some creditors called the timeline “objectionable”.